JOURNAL DESCRIPTION
The Medical Radiology and Radiation Safety journal ISSN 1024-6177 was founded in January 1956 (before December 30, 1993 it was entitled Medical Radiology, ISSN 0025-8334). In 2018, the journal received Online ISSN: 2618-9615 and was registered as an electronic online publication in Roskomnadzor on March 29, 2018. It publishes original research articles which cover questions of radiobiology, radiation medicine, radiation safety, radiation therapy, nuclear medicine and scientific reviews. In general the journal has more than 30 headings and it is of interest for specialists working in thefields of medicine¸ radiation biology, epidemiology, medical physics and technology. Since July 01, 2008 the journal has been published by State Research Center - Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency. The founder from 1956 to the present time is the Ministry of Health of the Russian Federation, and from 2008 to the present time is the Federal Medical Biological Agency.
Members of the editorial board are scientists specializing in the field of radiation biology and medicine, radiation protection, radiation epidemiology, radiation oncology, radiation diagnostics and therapy, nuclear medicine and medical physics. The editorial board consists of academicians (members of the Russian Academy of Science (RAS)), the full member of Academy of Medical Sciences of the Republic of Armenia, corresponding members of the RAS, Doctors of Medicine, professor, candidates and doctors of biological, physical mathematics and engineering sciences. The editorial board is constantly replenished by experts who work in the CIS and foreign countries.
Six issues of the journal are published per year, the volume is 13.5 conventional printed sheets, 88 printer’s sheets, 1.000 copies. The journal has an identical full-text electronic version, which, simultaneously with the printed version and color drawings, is posted on the sites of the Scientific Electronic Library (SEL) and the journal's website. The journal is distributed through the Rospechat Agency under the contract № 7407 of June 16, 2006, through individual buyers and commercial structures. The publication of articles is free.
The journal is included in the List of Russian Reviewed Scientific Journals of the Higher Attestation Commission. Since 2008 the journal has been available on the Internet and indexed in the RISC database which is placed on Web of Science. Since February 2nd, 2018, the journal "Medical Radiology and Radiation Safety" has been indexed in the SCOPUS abstract and citation database.
Brief electronic versions of the Journal have been publicly available since 2005 on the website of the Medical Radiology and Radiation Safety Journal: http://www.medradiol.ru. Since 2011, all issues of the journal as a whole are publicly available, and since 2016 - full-text versions of scientific articles. Since 2005, subscribers can purchase full versions of other articles of any issue only through the National Electronic Library. The editor of the Medical Radiology and Radiation Safety Journal in accordance with the National Electronic Library agreement has been providing the Library with all its production since 2005 until now.
The main working language of the journal is Russian, an additional language is English, which is used to write titles of articles, information about authors, annotations, key words, a list of literature.
Since 2017 the journal Medical Radiology and Radiation Safety has switched to digital identification of publications, assigning to each article the identifier of the digital object (DOI), which greatly accelerated the search for the location of the article on the Internet. In future it is planned to publish the English-language version of the journal Medical Radiology and Radiation Safety for its development. In order to obtain information about the publication activity of the journal in March 2015, a counter of readers' references to the materials posted on the site from 2005 to the present which is placed on the journal's website. During 2015 - 2016 years on average there were no more than 100-170 handlings per day. Publication of a number of articles, as well as electronic versions of profile monographs and collections in the public domain, dramatically increased the number of handlings to the journal's website to 500 - 800 per day, and the total number of visits to the site at the end of 2017 was more than 230.000.
The two-year impact factor of RISC, according to data for 2017, was 0.439, taking into account citation from all sources - 0.570, and the five-year impact factor of RISC - 0.352.
Medical Radiology and Radiation Safety. 2017. Vol. 62. No. 1. P. 27-31
DOI: 10.12737/25046
Lifetime Risk of Lung Cancer Death for Inhalation 239Pu
M.E. Sokolnikov, V.V. Vostrotin, A.V. Ephimov, E.K. Vasilenko, S.A. Romanov
Southern Ural Biophysics Institute. Chelyabinsk region, Ozersk, Russia, e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
M.E. Sokolnikov - Head of Lab., MD; V.V. Vostrotin - Head of Lab., PhD in Biological Sciences; A.V. Ephimov - Acting head of the division of radiation safety and dosimetry; E.K. Vasilenko - Chief, Southern Urals regional medical-dosimetry center; S.A. Romanov - Director, Southern Ural Biophysics Institute, PhD in Biological Sciences
Abstract
Aim of the study: Assessment of reliability of radiation safety standards after inhalation intake of Pu-239.
Material and methods: Using results of epidemiological study of lung cancer mortality in Mayak workers cohort and statistical data on all causes and lung cancer mortality in Russia the excess lifetime risk of lung cancer death was calculated.
Results: Current radiation safety standards restrict annual intake of Pu-239 class “S” at 1300 Bq/year level. The annual limit of intake is calculated in a way that the level of committed effective dose in 50 years after intake should not exceed 20 mSv. At the same time radiation safety standards restrict the level of the excess lifetime risk of cancer death at the level of 0.05 (for category A personnel) and/or annual increment of excess lifetime risk at the level 0.001. The equivalent dose of alpha-particles to the lung after 50 years of inhalation intake of Pu class “S” when calculated according to DOSE-2008 model will be 7 Sv. Given the pattern of dose accumulation over time after this scenario of Pu class “S” inhalation intake we calculated excess relative risk of lung cancer death, lifetime excess risk of lung cancer death and annual increment of excess lifetime risk. In 50 years of exposure to inhalation intake of Pu-239 class “S” the excess lifetime risk of lung cancer death will be 0.08, i.e. will exceed the 0.05 limit provided in radiation safety standards. The annual increment of the lifetime risk will exceed limit of 0.001, provided by the radiation safety standards, at age 45 and older.
These results demonstrate that the protection of personnel working with Pu-239 class “S” is insufficient in current radiation safety standards. One of the potential reasons is that lung contribution to total detriment for organism provided by ionizing radiation is averaged for all ages whereas for people of working age who contact to Pu at work this detriment doubles.
Key words: radiation safety standards, lifetime risk, inhalation intake, Plutonium-239
REFERENCES
- Normy radiacionnoj bezopasnosti (NRB-99/2009): Sanitarnye pravila i normativy SanPiN 2.6.1.2523-09. Moscow: Federal’nyj centr gigieny i jepidemiologii Rospotrednadzora. 2009. 100 p. (In Russ.).
- Pierce D.A., Shimizu Y., Preston D.L. et al. Studies of the mortality of atomic bomb survivors. Report 12. Part I. Cancer: 1950-1990. 1996. Radiat. Res. 2012. Vol. 178. No. 2. P. 61-87.
- Preston D.L., Shimizu Y., Pierce D.A. et al. Studies of mortality of atomic bomb survivors. Report 13: Solid cancer and noncancer disease mortality: 1950-1997. 2003. Radiat. Res. 2012. Vol. 178. No. 2. P. 146-172.
- Preston D.L., Ron E., Tokuoka S. et al. Solid cancer incidence in atomic bomb survivors: 1958-1998. Radiat. Res. 2007. Vol. 168. No. 1. P. 1-64.
- The 2007 Recommendations of the International Commission on Radiological Protection. ICRP publication 103. Ann. ICRP. 2007. Vol. 37. No. 2-4. P. 1-332.
- ICRP 1990 Recommendations of the International Commission on Radiological Protection. ICRP publication 60. Ann. ICRP. 1991. Vol. 21. No. 1-3.
- Gilbert E.S., Sokolnikov M.E., Preston D.L. et al. Lung cancer risks from plutonium: an updated analysis of data from the Mayak worker cohort. Radiat. Res. 2013. Vol. 179. No. 3. P. 332-342.
- Thomas D., Darby S., Fagnani F. et al. Definition and estimation of lifetime detriment from radiation exposures: principles and methods. Health Phys. 1992. Vol. 63. No. 3. P. 259-272.
- Human Mortality Database. University of California, Berkley (USA), Max Plank Institute for Demographic Research (Germany). Available from: www.mortality.org, www.humanmortality.de
- Shkol’nikov V.M., Mille F., Jertrish V., Vallen Zh. Sovremennye tendencii smertnosti po prichinam smerti v Rossii: 1965-1994. Na rus. i franc. jazykah. Prilozhenie na dvuh disketah. Paris, INED. 1996. 140 p. (In Russ.).
- Khokhryakov V.V., Khokhryakov V.F., Suslova K.G. et al. Mayak Worker Dosimetry System 2008 (MWDS-2008): assessment of internal dose from measurement results of plutonium activity in urine. Health Phys. 2013. 104. No. 4. P. 366-378.
For citation: Sokolnikov ME, Vostrotin VV, Ephimov AV, Vasilenko EK, Romanov S.A. Lifetime Risk of Lung Cancer Death for Inhalation 239Pu. Medical Radiology and Radiation Safety. 2017;62(2):27-31. Russian.DOI: 10.12737/25046
PDF (RUS) Full-text article (in Russian)